Fundraising FoxBerkeley Catalyst — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Newomics develops the UniESI system, a multiomics front-end platform using its M3 emitter and MEA chip "multispray" technologies for microflow and nanoflow LC-MS.
BiotechDeep TechHardwareBerkeley, US
Pan Mao(Director)inDaojing Wang(Executive Officer, Director)inPatrick Scannon(Director)
BoardTed Hou(Director)in
Co-investorsLDV PartnersMSA Capital
Fremont, US
Shrinivas Shetty(Executive Officer, Director)David Sungsu You(Director)Rami El Assal(Director)Kishore Karkera(Executive Officer)Art Zafiropoulo(Director)
Resilient Biotics uses microbiome genomics and data science to discover and develop non-antibiotic, precision microbial therapeutics derived from commensal microbial communities, aimed at preventing respiratory infectious diseases.
AI & Machine LearningBiotechHealthtechResearch Triangle Park, US
Rachelle Galvin(Executive Officer, Director)Christopher Belnap(Executive Officer, Director)Greg Werner(Executive Officer, Director)
BoardDrew Lanza(Director)inEric Eason(Director)John Peryam(Director)in
Co-investorsFulcrum Global Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.